PYGO2 and breast carcinoma: We found that Pygo2 was a target of miR‐516a‐3p, and miR‐516a‐3p suppressed breast cancer cell growth and metastasis by inhibiting the Pygo2/Wnt/β‐catenin pathway, which were never reported.